how many americans are on semaglutide Ozempic: 10 Things to Know About Food, Obesity & Weight Loss Watch: 136 million US adults

These results highlight significant heterogeneity in weight trajectories following sustained exposure to a GLP-1RA therapy and identifies factors associated with increased weight loss, likely reflecting a combination of biological, behavioral, and social factors

Two 131-patient cohorts with balanced baseline characteristics were formed by propensity score matching

Few medications have had such a meteoric rise as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), the GLP-1-based treatments for obesity t...

In a head-to-head comparison of the medications using electronic medical records data from Truveta, adults prescribed tirzepatide (Mounjaro/Zepbound, Eli Lilly) were more likely to achieve a 5%, 10%

Explore authoritative non-surgical and surgical solutions for rejuvenation.

New guidance has been issued by the British Menopause Society for women who are using both a GLP-1 Inhibitor (Semeglutide - Wegovy / Ozempic and Tirzepatide - Mounjaro ) and oral progesterone for endometrial protecti...